Brief: Inmed Pharmaceuticals Reports First Quarter 2023 Loss Per Share $4.06

InMed Pharmaceuticals

11/11/2022 23:56

Nov 11 (Reuters) - Inmed Pharmaceuticals Inc  INM.O :
    * INMED PHARMACEUTICALS REPORTS FIRST QUARTER FISCAL 2023
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * QTRLY LOSS PER SHARE $4.06

Source text for Eikon:  ID:nGNX98NzhJ 
Further company coverage:  INM.O 
 ((Reuters.Briefs@thomsonreuters.com;))